Vaxil Bio Ltd (VXL) — Strategic Asset Allocation Index
Vaxil Bio Ltd (VXL) has a Strategic Asset Allocation Index of 10.8% as of September 2025. Strategic assets (PP&E of CA$- plus long-term investments of CA$72.00K) total CA$72.00K, measured against net assets of CA$667.00K. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Vaxil Bio Ltd Strategic Asset Allocation Index (2013–2021)
This chart shows how Vaxil Bio Ltd's Strategic Asset Allocation Index has evolved across 6 annual periods from 2013 to 2021. As of September 2025, the index stands at 10.8%, representing strategic assets of CA$72.00K against net assets of CA$667.00K CAD. Explore VXL cash flow metrics to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Vaxil Bio Ltd (2013–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Vaxil Bio Ltd from 2013 to 2021, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Vaxil Bio Ltd market capitalisation.
| Year | SAAI | Strategic Assets (CAD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 0.1% | CA$2.00K | CA$2.00K | CA$- | CA$1.70 Million | ▼ -3.2 pp |
| 2020 | 3.4% | CA$27.00K | CA$27.00K | CA$- | CA$804.00K | ▼ -10.9 pp |
| 2018 | 14.3% | CA$62.00K | CA$62.00K | CA$- | CA$435.00K | ▼ -10.9 pp |
| 2016 | 25.2% | CA$165.00K | CA$165.00K | CA$- | CA$656.00K | ▼ -56.1 pp |
| 2014 | 81.2% | CA$28.00K | CA$28.00K | CA$- | CA$34.48K | ▲ +22.7 pp |
| 2013 | 58.5% | CA$110.00K | CA$110.00K | CA$- | CA$187.94K | — |